M.C. Bibby
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 4
- Microbiology top 5%
- Biotechnology top 5%
- Cancer Research and Treatments 4
- Cancer Research top 10%
- Oncology top 10%
- Cancer Treatment and Pharmacology 4
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 3
-
- Cancer therapeutics and mechanisms 5
-
- Pharmacogenetics and Drug Metabolism 4
-
- Synthesis and biological activity 3
- Co-authors
- Alison MooreJohn A. DoublePaul M. LoadmanJ A DoubleGwendolen ReesRoger M. PhillipsKetan C. RupareliaL H Patterson
- Cited by
- ToxicologyMicrobiologyBiotechnology
- Journals
- British Journal of Cancer (7 papers)European Journal of Cancer (3 papers)Parasitology Research (2 papers)
- Partner nations
- United KingdomIrelandNetherlands
In The Last Decade
M.C. Bibby
39 papers receiving 982 citations
Peers
Comparison fields: 5 of 95
- Toxicology 71
- Microbiology 103
- Biotechnology 131
- Cancer Research 215
- Oncology 283
Countries citing papers authored by M.C. Bibby
This map shows the geographic impact of M.C. Bibby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Bibby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Bibby more than expected).
Fields of papers citing papers by M.C. Bibby
This network shows the impact of papers produced by M.C. Bibby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Bibby. The network helps show where M.C. Bibby may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.C. Bibby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 237 | |
| 2 | Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate. | 2003 | 42 |
| 3 | 2001 | 17 | |
| 4 | 2000 | 14 | |
| 5 | 2000 | 65 | |
| 6 | 1999 | 7 | |
| 7 | 1999 | 11 | |
| 8 | 1999 | 8 | |
| 9 | 1999 | 34 | |
| 10 | 1994 | 24 | |
| 11 | 1993 | 89 | |
| 12 | 1992 | 4 | |
| 13 | 1988 | 4 | |
| 14 | 1988 | 5 | |
| 15 | 1988 | 15 | |
| 16 | 1988 | 16 | |
| 17 | 1988 | 6 | |
| 18 | 1987 | 4 | |
| 19 | 1979 | 20 | |
| 20 | 1972 | 29 |
About M.C. Bibby
M.C. Bibby is a scholar working on Toxicology, Oncology and Pharmacology, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cancer Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Synthesis and biological activity (3 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Toxicology (71 citations), Microbiology (103 citations) and Biotechnology (131 citations). M.C. Bibby has collaborated with scholars based in United Kingdom, Ireland and Netherlands. Frequent co-authors include Alison Moore, John A. Double, Paul M. Loadman, J A Double, Gwendolen Rees, Roger M. Phillips, Ketan C. Ruparelia, L H Patterson, Ian J. Stratford and T.C. Jenkins. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Parasitology Research, Cancer Chemotherapy and Pharmacology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.